Brainvectis gave oral presentations at the European Society of Gene and Cell Therapy (ESGCT) conference

By October 15, 2018Non classé

Brainvectis will participate in the European Society of Gene and Cell Therapy, that will be held at Lausanne, Switzerland.

Nathalie Cartier will give an oral presentation on Tuesday 16th October during the CNS session entitled « Gene Therapy for Huntington’s disease ».

Sandro Alves will give an oral presentation on friday 19th October during the CNS session entitled « CYP46A1 gene therapy alleviates spinocerebellar ataxia in mouse models ».